Colorectal cancer (CRC) is the world's third most prevalent cancer and the main cause of
cancer-related mortality. A lot of work has been put into improving CRC patients' clinical …

BACKGROUND Circulating microRNAs have been proposed as disease biomarkers that
may aid in risk assessment, diagnosis, prognosis, and monitoring of treatment response …

MicroRNAs (miRNAs) belong to a class of small non-coding RNAs that regulate numerous
biological processes by targeting a broad set of messenger RNAs. Recently, miRNAs have …

The effective and efficient management of cancer patients relies upon early diagnosis and/or
the monitoring of treatment, something that is often difficult to achieve using standard tissue …

The simultaneous analysis of the levels of multiple microRNAs (miRNAs) is critical to the
early diagnosis of cancer. However, this analysis is challenging because of the low …

Colorectal cancer (CRC) is the third most common cancer and leading cause of cancer
related deaths worldwide. Despite recent advancements in surgical and molecular targeted …

MicroRNAs (miRNAs) are small single-stranded RNAs that repress mRNA translation and
trigger mRNA degradation. Of the∼ 1900 miRNA-encoding genes present in the human …

Background: Colorectal cancer (CRC) is common and associated with significant mortality.
Current screening methods for CRC lack patient compliance. microRNAs (miRNAs) …

Background Colorectal cancer (CRC) is a major worldwide health problem due to its high
prevalence and mortality rate. T-cell intracellular antigen 1 (TIA1) is an important tumor …

Cancer initiation and progression is controlled by both genetic and epigenetic events.
Epigenetics refers to the study of mechanisms that alter gene expression without …